Validating Reference Samples for Comparison in a Regulated ELISPOT Assay

Validation of Cell-Based Assays in the GLP Setting: A Practical Guide

Volumn , Issue , 2008, Pages 127-146

  Tary Lehmann, Magdalena ^a   Hamm, Christina D ^b   Lehmann, Paul V ^b  

^a Cellular Technology Ltd   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ELISPOT; PBMC; T cells

Indexed keywords

EID: 84889342332     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987810.ch9     Document Type: Chapter

References (32)

1. Anthony DD and Lehmann PV (2003). T-cell epitope mapping using the ELISPOT approach. Methods, 29, 260-269.
2. Anthony DD, Valdez H, Post AB, Carlson NL, Heeger PS and Lehmann PV (2002). Comprehensive determinant mapping of the hepatitis C-specific CD8 cell repertoire reveals unpredicted immune hierarchy. Clin Immunol, 103, 264-276.
3. Carter LL and Swain SL (1997). Single cell analyses of cytokine production. Curr Opin Immunol, 9, 177-182.
4. Cox JH, Ferrari G, Kalams SA, Lopaczynski W, Oden N and D'souza MP (2005). Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res Hum Retroviruses, 21, 68-81.
5. Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, and Cox JH (2002). A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods, 260, 157-172.
6. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L and Ouchterlony O (1988). Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells, J Immunol Methods, 110, 29-36.
7. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O and Tarkowski A (1983). A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells, J Immunol Methods, 65, 109-121.
8. Forsthuber T, Yip HC and Lehmann PV (1996). Induction of TH1 and TH2 immunity in neonatal mice, Science, 271, 1728-1730.
9. Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ and Heeger PS (2002). Evolution of the enzymelinked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool, Am J Transplant, 2, 857-866.
10. Guerkov RE, Targoni OS, Kreher CR, Boehm BO, Herrera MT, Tary-Lehmann M, Lehmann PV and Schwander SK (2003). Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine, J Immunol Methods, 279, 111-121.
11. Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, and Tary-Lehmann M (1999). Pretransplant frequency of donor-specific, IFN-gammaproducing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes, J Immunol, 163, 2267-2275.
12. Helms T, Boehm BO, Asaad RJ, Trezza RP, Lehmann PV and Tary-Lehmann M (2000). Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients, J Immunol, vol. 164, no. 7, pp. 3723-3732.
13. Hesse MD, Karulin AY, Boehm BO, Lehmann PV and Tary-Lehmann M (2001). A T cell clone's avidity is a function of its activation state, J Immunol, 167, 1353-1361.
14. Janetzki S, Cox JH, Oden N and Ferrari G (2005). Standardization and validation issues of the ELISPOT assay, Methods Mol Biol, 302, 51-86.
15. Karulin AY, Hesse MD, Tary-Lehmann M and Lehmann PV (2000). Single-cytokineproducing CD4 memory cells predominate in type 1 and type 2 immunity, J Immunol, 164, 1862-1872.
16. Kleen TO, Asaad R, Landry SJ, Boehm BO and Tary-Lehmann M (2004). Tc1 effector diversity shows dissociated expression of granzyme B and interferon-gamma in HIV infection, AIDS, 18, 383-392.
17. Kleen TO, Kadereit S, Fanning LR, Jaroscak J, Fu P, Meyerson HJ, Kulchycki L, Slivka LF, Kozik M, Tary-Lehmann M and Laughlin MJ (2005). Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation, Transplantation, 80, 1316-1322.
18. Kreher CR, Dittrich MT, Guerkov R, Boehm BO and Tary-Lehmann M (2003). CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays, J Immunol Methods, 278, 79-93.
19. Lehmann PV (2005). Image analysis and data management of ELISPOT assay results, Methods Mol Biol, 302, 117-132.
20. Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, Payne JK, Kuus-Reichel K, Chang JC, Summers A, Clay TM, Morse MA, Lyerly HK, DeLaRosa C, Ankerst DP and Disis ML (2005). Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT, BMC Immunol, 6, 17.
21. McCutcheon M, Wehner N, Wensky A, Kushner M, Doan S, Hsiao L, Calabresi P, Ha T, Tran TV, Tate KM, Winkelhake J and Spack EG (1997). A sensitive ELISPOT assay to detect low-frequency human T lymphocytes, J Immunol Methods, 210, 149-166.
22. McHugh S, Deighton J, Rifkin I and Ewan P (1996). Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture, Eur J Immunol, 26, 1260-1265.
23. Moretto WJ, Drohan LA and Nixon DF (2000). Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry, AIDS, 14, 2625-2627.
24. Ott PA, Herzog BA, Quast S, Hofstetter HH, Boehm BO, Tary-Lehmann M, Durinovic-Bello I, Berner BR and Lehmann PV (2005). Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls, Clin Immunol, 115, 102-114.
25. Pahar B, Li J, Rourke T, Miller CJ and McChesney MB (2003). Detection of antigenspecific T cell interferon gamma expression by ELISPOT and cytokine flow cytometry assays in rhesus macaques, J Immunol Methods, 282, 103-115.
26. Rau H, Revets H, Balmelli C, McCullough KC, and Summerfield A (2006). Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo, Vet Res, 37, 155-168.
27. Rininsland FH, Helms T, Asaad RJ, Boehm BO and Tary-Lehmann M (2000). Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity, J Immunol Methods, 240, 143-155.
28. Schielen P, van Rodijnen W, Tekstra J, Albers R and Seinen W (1995). Quantification of natural antibody producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support, J Immunol Methods, 188, 33-41.
29. Sedgwick JD and Holt PG (1983). A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells, J Immunol Methods, 57, 301-309.
30. Shaw RD, Merchant AA, Groene WS and Cheng EH (1993). Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year, J Clin Microbiol, 31, 188-191.
31. Smith JG, Liu X, Kaufhold RM, Clair J and Caulfield MJ (2001). Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus, Clin Diagn Lab Immunol, 8, 871-879.
32. Tanguay S and Killion JJ (1994). Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells, Lymphokine Cytokine Res, 13, 259-263.